OncoResponse
PrivateLast Round
VC Round
May 18, 2023
Total Funding Raised
$169.36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
OncoResponse is a biotechnology company that develops cancer immunotherapies by leveraging insights from the immune systems of patients who have shown exceptional responses to checkpoint inhibition.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoResponse Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
OncoResponse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 18, 2023 | ||||
| Grant | May 17, 2023 | ||||
| Debt | Feb 16, 2022 | ||||
| Series C | Mar 31, 2021 | ||||
| Series B | Sep 11, 2018 | ||||
Series A | Mar 9, 2017 |
Key People
Founding team and executive leadership
OncoResponse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series C, Series B |
| GreatPoint Ventures | Series A |
| InterVest | VC Round |
| Cancer Prevention & Research Institute of Texas | Grant |
| HT Family Office | Series B |
| Magnetar Capital | Series C |
| Yonjin Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors grew 70% MoM, from 667 to 1.1K.
- May 18, 2023
Received $13M from the Cancer Prevention & Research Institute of Texas.
OncoResponse Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncoResponse's valuation, stock price, and market status.